Aug 22, 2025

Aug 22, 2025

Rapid Anxiety Relief in Early Pregnancy with tDCS + CET

Rapid Anxiety Relief in Early Pregnancy with tDCS + CET

Rapid Anxiety Relief in Early Pregnancy with tDCS + CET

Learn how EASE treated Persistent anxiety, physiological restlessness, palpitations, poor sleep, irritability, and reduced concentration

A laptop, tablet and mobile on a table
A laptop, tablet and mobile on a table
A laptop, tablet and mobile on a table
women's brown sleeveless shirt

EASE Case Study

EASE Case Study

Clinical Success Team

Clinical Success Team

Patient Identification: Swati (pseudonym), 34-year-old female

Clinical Status: 5 weeks pregnant via IVF, no prior psychiatric history

Primary Complaint: Persistent anxiety, physiological restlessness, palpitations, poor sleep, irritability, and reduced concentration

Diagnosis: Generalized Anxiety Disorder (F41.1), with prominent somatic features

Baseline Assessments:

  • Hamilton Anxiety Rating Scale (HAM-A): 26 (Moderate–Severe)

  • Hamilton Depression Rating Scale (HAM-D): 18 (Mild–Moderate)

Intervention

Treatment Modality: Active anodal tDCS administered through the Ease device, paired with Cognitive Emotional Training (CET) modules.

Protocol Parameters:

  • Electrode Montage: Anode – Left DLPFC (F3); Cathode – Right DLPFC (F4)

  • Current Intensity: 2 mA

  • Session Duration: 20 minutes

  • Total Sessions: 10 (over 12 days)

  • Concomitant Therapy: No psychotropic medication during or prior to intervention

Cognitive Emotional Training Components:

  • Emotional N-Back Task: targeting affective working memory

  • Flanker Task: improving cognitive control and interference resolution

  • Corsi Block Task: enhancing visuospatial working memory

  • Go/No-Go Task: strengthening response inhibition

Each CET task was delivered with adaptive difficulty based on accuracy, ensuring sustained engagement and progressive activation of cognitive–emotional regulatory circuits.

Outcome Measures

Symptom severity was evaluated pre- and post-treatment using validated clinician-rated scales:

  • Hamilton Anxiety Rating Scale (HAM-A)

  • Hamilton Depression Rating Scale (HAM-D)

Clinical progress was also tracked through subjective self-reports on mood stability, irritability, and functional capacity.

Results

After 10 sessions, substantial symptomatic improvement was observed:

Measure

Baseline

Post-Intervention

% Reduction

HAM-A

26

12

↓ 53.8%

HAM-D

18

9

↓ 50.0%

Clinical Observations

  • Marked reduction in autonomic hyperarousal (palpitations, muscle tension, restlessness)

  • Restoration of sleep continuity and energy levels

  • Enhanced emotional regulation and frustration tolerance

  • Reduction in interpersonal reactivity and improved occupational functioning

No adverse effects were reported throughout the course of stimulation.